On February 9th, the semiconductor chip sector experienced a significant surge. The "All-Chip" Sci-Tech Innovation Chip ETF Huabao (589190) opened higher and continued to climb, with its on-market price currently up over 3%. The majority of the 50 constituent stocks within the Shanghai Stock Exchange Science and Technology Innovation Board Chip Index advanced. Among the heavyweight components, Verisilicon Microelectronics surged more than 16%, while Cambricon Technologies rose over 5%. Hygon Information, Lattice Semiconductor, and Huahong Group also saw gains exceeding 3%.
The positive movement follows recent corporate announcements. Google's parent company, Alphabet, projected its capital expenditures for 2026 to reach between $175 billion and $185 billion, nearly double the scale anticipated for 2025. Amazon also revised its forecast upwards to $200 billion, representing a year-over-year increase of more than 50%. Furthermore, Amazon's self-developed Trainium series of ASIC chips are reportedly in a state of being "completely sold out." The upcoming Trainium3 chip is expected to offer approximately 40% better price-performance compared to its predecessor, with its production capacity for the year almost fully booked in advance.
Analysts from Guojin Securities pointed out that the number of ASIC chips deployed by leading global cloud providers is expected to see explosive growth during 2026-2027, suggesting that the core computing hardware supply chain will continue to benefit significantly.
Guosheng Securities added that global semiconductor equipment sales are projected to reach $145 billion in 2026. With domestic wafer fabrication plants showing clear intentions to expand production, and amid regional political influences, local equipment manufacturers are poised to benefit substantially from a dual catalyst of "strengthened localization trends and accelerated capacity expansion." This could lead to a potential revaluation of domestic semiconductor equipment companies in 2026.
For investors looking to position for this "super-cycle" in the chip industry, high-volatility instruments are an option. Public information indicates that the Sci-Tech Innovation Chip ETF Huabao (589190) passively tracks the Shanghai Stock Exchange Science and Technology Innovation Board Chip Index. This index encompasses 50 companies involved in semiconductor materials and equipment, chip design, chip manufacturing, and chip packaging and testing. It provides comprehensive exposure to the chip industry supply chain, with a weight exceeding 90% allocated to core segments like integrated circuits and semiconductor equipment, reflecting its high concentration in advanced, high-barrier technologies.
Data shows that as of the end of 2025, the Shanghai Stock Exchange Science and Technology Innovation Board Chip Index had achieved an annualized return of 17.93% since its base date, significantly outperforming comparable indices such as the STAR Market ChiNext Semiconductor Index, the Guozheng Chip Index, and the CSI All Share Semiconductor Index. It also demonstrated smaller maximum drawdowns, indicating a superior risk-return profile.
Source: Shanghai and Shenzhen Stock Exchanges, etc. The Sci-Tech Innovation Chip ETF Huabao passively tracks the Shanghai Stock Exchange Science and Technology Innovation Board Chip Index. The index's base date is December 31, 2019, and its release date was June 13, 2022. The composition of the index's constituent stocks is adjusted periodically according to its compilation rules. The index's backtested historical performance is not indicative of its future results. The index's performance for the last five full years is as follows: 2021: +6.87%, 2022: -33.69%, 2023: +7.26%, 2024: +34.52%, 2025: +61.33%. The composition of the index's constituent stocks is adjusted periodically according to its compilation rules. The index's backtested historical performance is not indicative of its future results.
ETF Fee Information: When subscribing for or redeeming fund shares, subscription and redemption agents may charge a commission of up to 0.5%, which includes relevant fees charged by stock exchanges and registration institutions.
Risk Disclosure: This product is issued and managed by Huabao Fund. Selling agents do not assume responsibility for the product's investment, redemption, or risk management. Investors should carefully read the "Fund Contract," "Prospectus," "Fund Product Summary," and other legal fund documents to understand the fund's risk-return characteristics and select a product suitable for their own risk tolerance. The fund manager assesses this fund's risk rating as R4 - Medium-High Risk, suitable for investors with a suitability rating of C4 and above. The performance of other funds managed by the fund manager does not guarantee this fund's performance. Past performance of the fund is not indicative of its future results. Funds carry risks, and investment requires caution. Selling institutions (including the fund manager's direct sales channels and other selling institutions) evaluate the risk of this fund based on relevant laws and regulations. Investors should pay attention to the suitability opinions provided by the fund manager in a timely manner. Suitability opinions from different selling institutions may not necessarily be consistent, and the risk rating results for the fund product provided by fund selling institutions shall not be lower than the risk rating result determined by the fund manager. There may be differences between the fund's risk-return characteristics described in the fund contract and its risk level due to different consideration factors. Investors should understand the fund's risk-return situation and make careful choices based on their investment objectives, horizon, experience, and risk tolerance, bearing the risks themselves. The China Securities Regulatory Commission's registration of this fund does not indicate a substantive judgment or guarantee of its investment value, market prospects, or returns. Funds carry risks, and investment requires caution.
A MACD golden cross signal has formed, indicating positive momentum for these stocks.
Comments